310 related articles for article (PubMed ID: 11070993)
1. [Acute myelogenous leukemia and myelodysplastic syndrome after treatment with cytostatic agents].
Abrahamsen AF
Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2542-5. PubMed ID: 11070993
[TBL] [Abstract][Full Text] [Related]
2. Myelodysplastic syndrome/acute myelogenous leukaemia after adjuvant chemotherapy with pyrimidine anti-metabolites in three patients.
Pitini V; Arrigo C; Aloi G; Righi M; Falduto M; Teti D
Haematologica; 2001 Oct; 86(10):E30. PubMed ID: 11602437
[No Abstract] [Full Text] [Related]
3. Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone.
Au WY; Chan LC; Liang R; Kwong YL
Am J Hematol; 2006 Jun; 81(6):471-3. PubMed ID: 16680740
[No Abstract] [Full Text] [Related]
4. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: possible role of cytarabine.
Arana-Yi C; Block AW; Sait SN; Ford LA; Barcos M; Baer MR
Leuk Res; 2008 Jul; 32(7):1043-8. PubMed ID: 18093651
[TBL] [Abstract][Full Text] [Related]
5. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
6. Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide.
Praga C; Bergh J; Bliss J; Bonneterre J; Cesana B; Coombes RC; Fargeot P; Folin A; Fumoleau P; Giuliani R; Kerbrat P; Hery M; Nilsson J; Onida F; Piccart M; Shepherd L; Therasse P; Wils J; Rogers D
J Clin Oncol; 2005 Jun; 23(18):4179-91. PubMed ID: 15961765
[TBL] [Abstract][Full Text] [Related]
7. Secondary myelodysplastic syndromes and leukemias.
Giles FJ; Koeffler HP
Curr Opin Hematol; 1994 Jul; 1(4):256-60. PubMed ID: 9371291
[TBL] [Abstract][Full Text] [Related]
8. Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes.
Ballen KK; Antin JH
Hematol Oncol Clin North Am; 1993 Apr; 7(2):477-93. PubMed ID: 8468276
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk.
Patt DA; Duan Z; Fang S; Hortobagyi GN; Giordano SH
J Clin Oncol; 2007 Sep; 25(25):3871-6. PubMed ID: 17664457
[TBL] [Abstract][Full Text] [Related]
10. [Therapy-induced leukemia -- an underestimated complication of antineoplastic chemotherapy?].
Dührsen U
Zentralbl Gynakol; 2005 Aug; 127(4):235-41. PubMed ID: 16037905
[TBL] [Abstract][Full Text] [Related]
11. Therapy-related myeloid neoplasms.
Czader M; Orazi A
Am J Clin Pathol; 2009 Sep; 132(3):410-25. PubMed ID: 19687318
[TBL] [Abstract][Full Text] [Related]
12. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
13. Therapy-related myelodysplastic syndromes.
Park DJ; Koeffler HP
Semin Hematol; 1996 Jul; 33(3):256-73. PubMed ID: 8819235
[No Abstract] [Full Text] [Related]
14. Myelodysplastic syndrome and acute leukaemia following treatment of soft tissue sarcoma.
de Graeff A; Vendrik CP; Pinedo HM
Neth J Med; 1989 Jun; 34(5-6):251-7. PubMed ID: 2671758
[TBL] [Abstract][Full Text] [Related]
15. [Therapy-related acute leukaemia and myelodysplastic syndrome].
Díaz Beveridge R; Aparicio Urtasun J
An Med Interna; 2003 May; 20(5):257-68. PubMed ID: 12831302
[TBL] [Abstract][Full Text] [Related]
16. Therapy-related myelodysplastic syndrome/acute myeloid leukemia M2 and translocation (8;21).
Sakugawa M; Kojima K; Kaneda K; Masuda K; Dansako H; Shinagawa K; Ishimaru F; Ikeda K; Niiya K; Harada M; Tanimoto M
Ann Hematol; 2001 Dec; 80(12):763-6. PubMed ID: 11797121
[TBL] [Abstract][Full Text] [Related]
17. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
[TBL] [Abstract][Full Text] [Related]
18. Re: Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Clavarezza M; Del Mastro L; Pronzato P; Bruzzi P; Venturini M
J Natl Cancer Inst; 2007 Jul; 99(13):1050-1; author reply 1051-2. PubMed ID: 17596581
[No Abstract] [Full Text] [Related]
19. Re: Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Warren JL; Brown ML
J Natl Cancer Inst; 2007 Jul; 99(13):1050; author reply 1051-2. PubMed ID: 17596580
[No Abstract] [Full Text] [Related]
20. Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy.
Mattiuzzi GN; Kantarjian H; Faderl S; Lim J; Kontoyiannis D; Thomas D; Wierda W; Raad I; Garcia-Manero G; Zhou X; Ferrajoli A; Bekele N; Estey E
Cancer; 2004 Feb; 100(3):581-9. PubMed ID: 14745876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]